Navigation Links
ZyStor to exhibit cell disorder treatments

Milwaukee, Wis. - Loren Peterson, president and CEO of ZyStor Therapeutics, Inc. is looking forward to showcasing his Milwaukee company for attendees of this year's Midwestern bioscience forum.

As a presenter at the conference, Peterson will represent Wisconsin biotechnology companies with another presenter, Dr. Irene Hrusovsky, CEO of Madison-b......

Full article >>> estimated to affect 1 in 7,700 live births.

"Our intellectual property surrounds a way of attaching a peptide tag to these enzymes - to better target receptors on cell surfaces on clinically significant tissues - so that it can get into the lysosome of the cell, where it can then reduce the storage material that builds up in patients," Peterson explained.

ZyStor is in preclinica......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 09/12/06


Related biology technology :

1. ZyStor seeks to raise $15M for clinical trials
2. Milwaukee area biotech ZyStor seeks more funding
3. ZyStor receives first funding and buys theraputics for rare diseases
4. Engineers help turn science into interactive exhibits
5. Nanotech exhibit opens at UW-Madison
6. Gender hormones may lend to social disorder therapies
7. TomoTherapy leads the industry in CT image-guided treatments
8. Medical College getting $18.1 million to study radiation damage treatments
9. Research on fruit flies opens up possibilities for human treatments
10. UW discovery could lead to new TB treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... , ... Today, researchers can fast-track sample collection and analysis ... biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the addition ... insulin and other relevant biomarkers can be extensively studied through a non-invasive sample ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):